Integrated insights from PMR to create a patient journey map, covering diagnosis, treatment lines, and market dynamics.
Focused on key aspects of the patient journey, including treatment stages and market positioning, to ensure the insights were aligned with the real-world data.
Defined a stable cohort using claims data, aligning it with relevant business rules and criteria for accurate longitudinal analysis.
Implemented treatment lines (LOT) and analyzed patient progress from diagnosis (Dx) to treatment (Rx), uncovering insights into drug switches and treatment outcomes.
Developed a concise and actionable patient journey map addressing key business questions (KBQs).
Identified patient opportunities across treatment lines, including drug switches.
Discovered an unmet need in the first-line (1L) treatment for patients reliant on long-term steroid use, highlighting the demand for a sustainable, user-friendly therapy.
